News & Analysis as of

Off-Label Use Informed Consent

Buckingham, Doolittle & Burroughs, LLC

Hydroxychloroquine and Chloroquine: What We Know About Off-Label Use of Drugs and Potential Malpractice Claims in Ohio

On April 24, 2020, the FDA issued a Drug Safety Communication about the known side effects of hydroxychloroquine and chloroquine – the antimalarial drugs being used to treat Covid-19. These side effects include serious and...more

1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide